The reported statements, read against the company's own industry.
Financials view
Market Capitalization
543.70MUSD
vs all stocks (USD)
Updated Oct 28, 2026
Revenue (TTM)
225.87MUSD
vs all stocks (USD)
Updated Oct 28, 2026
Profit Margin
-48.58%
Updated Oct 28, 2026
Beta
1.25x
vs all stocks
Updated Oct 28, 2026
52-Week Change
-8.28%
vs all stocks
Updated Oct 28, 2026
Forward Annual Dividend Yield
0.00%
vs all stocks
Updated Oct 28, 2026
Market Capitalization
543.70MUSD
vs all stocks (USD)
Updated Oct 28, 2026
Enterprise Value
653.73MUSD
vs all stocks (USD)
Updated Oct 28, 2026
Forward P/E
-19.25x
Updated Oct 28, 2026
Price to Sales (TTM)
2.11x
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 2.41×.Updated Oct 28, 2026
Price to Book (MRQ)
68.95x
Updated Oct 28, 2026
Enterprise to Revenue
2.89x
Updated Oct 28, 2026
Enterprise to EBITDA
-9.86x
Updated Oct 28, 2026
Gross Margin
30.95%
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 22.47%.Updated Oct 28, 2026
Profit Margin
-48.58%
Updated Oct 28, 2026
Operating Margin
-141.97%
Updated Oct 28, 2026
Return on Assets (TTM)
-15.51%
Updated Oct 28, 2026
Return on Equity (TTM)
-178.56%
Updated Oct 28, 2026
Revenue (TTM)
225.87MUSD
vs all stocks (USD)
Updated Oct 28, 2026
Revenue per Share (TTM)
1.33USDUpdated Oct 28, 2026
Quarterly Revenue Growth
104.10%
Updated Oct 28, 2026
Gross Profit (TTM)
50.76MUSD
vs all stocks (USD)
Updated Oct 28, 2026
EBITDA (TTM)
-66.33MUSD
vs all stocks (USD)
Updated Oct 28, 2026
Net Income (TTM)
-112.15MUSD
vs all stocks (USD)
Updated Oct 28, 2026
Quarterly Earnings Growth (YoY)
104.05%
Updated Oct 28, 2026
Operating Cash Flow (TTM)
-102.64MUSD
vs all stocks (USD)
Updated Oct 28, 2026
Levered Free Cash Flow (TTM)
-115.56MUSD
vs all stocks (USD)
Updated Oct 28, 2026
Forward Annual Dividend Yield
0.00%
vs all stocks
Updated Oct 28, 2026
Trailing Annual Dividend Rate
0.00USDUpdated Oct 28, 2026
Trailing Annual Dividend Yield
0.00%
vs all stocks
Updated Oct 28, 2026
Minority Interest (Equity)
21.13MUSDFY2025 · Dec 31, 2025
Revenue
203.67MUSDFY2025 · Dec 31, 2025
Cost of Goods Sold
155.68MUSDFY2025 · Dec 31, 2025
Gross Profit
47.99MUSDFY2025 · Dec 31, 2025
Operating Income
-74.37MUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-95.89MUSDFY2025 · Dec 31, 2025
Income Tax Expense
7.76MUSDFY2025 · Dec 31, 2025
Net Income
-103.66MUSDFY2025 · Dec 31, 2025
EBIT
-87.43MUSDFY2025 · Dec 31, 2025
EBITDA (Income Statement)
-73.53MUSDFY2025 · Dec 31, 2025
Research & Development
14.63MUSDFY2025 · Dec 31, 2025
Selling, General & Administrative
94.88MUSDFY2025 · Dec 31, 2025
Non-operating Interest Income
1.10MUSDFY2025 · Dec 31, 2025
Non-operating Interest Expense
8.46MUSDFY2025 · Dec 31, 2025
EPS (Basic)
-0.6500USDFY2025 · Dec 31, 2025
EPS (Diluted)
-0.6500USDFY2025 · Dec 31, 2025
Basic Shares Outstanding
160.53MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
160.53MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-103.66MUSDFY2025 · Dec 31, 2025
Minority Interests (P&L)
47.00KUSDFY2025 · Dec 31, 2025
Operating Cash Flow
-80.27MUSDFY2025 · Dec 31, 2025
Free Cash Flow
-121.36MUSDFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
103.44MUSDFY2025 · Dec 31, 2025
Income Tax Paid
643.00KUSDFY2025 · Dec 31, 2025
Interest Paid
3.40MUSDFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-103.66MUSDFY2025 · Dec 31, 2025
Depreciation & Amortization
5.73MUSDFY2025 · Dec 31, 2025
Deferred Taxes (CF)
7.15MUSDFY2025 · Dec 31, 2025
Stock-based Compensation
36.71MUSDFY2025 · Dec 31, 2025
Other Non-cash Items
4.68MUSDFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-24.76MUSDFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-6.12MUSDFY2025 · Dec 31, 2025
Capital Expenditures
-41.09MUSDFY2025 · Dec 31, 2025
Net Intangibles (CF)
-1.37MUSDFY2025 · Dec 31, 2025
Other Investing Activity
-2.14MUSDFY2025 · Dec 31, 2025
Net Investing Cash Flow
-43.23MUSDFY2025 · Dec 31, 2025
Long-term Debt Issuance
151.30MUSDFY2025 · Dec 31, 2025
Long-term Debt Payments
-56.56MUSDFY2025 · Dec 31, 2025
Other Financing Charges
20.73MUSDFY2025 · Dec 31, 2025
Net Financing Cash Flow
122.31MUSDFY2025 · Dec 31, 2025
Shares Outstanding
179.94MSharesUpdated Oct 28, 2026
Float Shares
147.13MSharesUpdated Oct 28, 2026
Shares Short
33.74MSharesUpdated Oct 28, 2026
Short Ratio
8.09days
vs all stocks
Updated Oct 28, 2026
Short % of Shares Outstanding
22.23%
vs all stocks
Provider-reported. Shares Short ÷ Shares Outstanding on this page gives 18.75%.Updated Oct 28, 2026
% Held by Insiders
17.66%
vs all stocks
Updated Oct 28, 2026
% Held by Institutions
61.34%
vs all stocks
Updated Oct 28, 2026
Total Cash (MRQ)
93.38MUSD
vs all stocks (USD)
Updated Oct 28, 2026
Total Cash per Share (MRQ)
0.5140USDUpdated Oct 28, 2026
Total Debt (MRQ)
244.97MUSD
vs all stocks (USD)
Updated Oct 28, 2026
Total Debt to Equity (MRQ)
7.51x
Updated Oct 28, 2026
Current Ratio (MRQ)
1.19x
Updated Oct 28, 2026
Book Value per Share (MRQ)
0.0380USDUpdated Oct 28, 2026
Total Assets
312.88MUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
121.07MUSDFY2025 · Dec 31, 2025
Total Liabilities
224.26MUSDFY2025 · Dec 31, 2025
Total Non-current Assets
191.81MUSDFY2025 · Dec 31, 2025
Total Non-current Liabilities
59.24MUSDFY2025 · Dec 31, 2025
Total Current Liabilities
165.02MUSDFY2025 · Dec 31, 2025
Cash & Cash Equivalents
58.26MUSDFY2025 · Dec 31, 2025
Other Short-term Investments
325.00KUSDFY2025 · Dec 31, 2025
Accounts Receivable
25.94MUSDFY2025 · Dec 31, 2025
Inventory
139.00KUSDFY2025 · Dec 31, 2025
Accounts Payable
30.84MUSDFY2025 · Dec 31, 2025
Short-term Debt
57.18MUSDFY2025 · Dec 31, 2025
Deferred Revenue
6.61MUSDFY2025 · Dec 31, 2025
Long-term Debt
39.55MUSDFY2025 · Dec 31, 2025
Common Stock (Book)
17.00KUSDFY2025 · Dec 31, 2025
Retained Earnings
-487.43MUSDFY2025 · Dec 31, 2025
Total Shareholders' Equity
88.62MUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
2.46USDUpdated Oct 28, 2026
52-Week High
6.64USDUpdated Oct 28, 2026
52-Week Change
-8.28%
vs all stocks
Updated Oct 28, 2026
Beta
1.25x
vs all stocks
Updated Oct 28, 2026
50-Day MA
3.69USDUpdated Oct 28, 2026
200-Day MA
3.97USDUpdated Oct 28, 2026
Avg 10-Day Volume
4.24MSharesUpdated Oct 28, 2026
Avg 30-Day Volume
4.09MSharesUpdated Oct 28, 2026
Diluted EPS (TTM)
-0.6900USDUpdated Oct 28, 2026
Other Income / Expense
-14.16MUSDFY2025 · Dec 31, 2025
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score -1.17: distress zoneCritical
Altman Z-Score: -1.17
Supply Chain
Upstream position: supplies 5 industries, depends on 3Notable
Outgoing: 5.00Incoming: 3.00
Companies that share the same coordination system — how they create, deliver, or capture value.